1. Enheten
  2. Ansatte
  3. Emilio Besada
#
#
Institutt for klinisk medisin emilio.besada@uit.no Tromsø

Emilio Besada

Universitetslektor

Stillingsbeskrivelse

Universitetslektor

 

  • Davis, Simon; Lott, Alexander; Besada, Emilio. General practitioner confirmed complete Achilles tendon rupture using pocket-sized ultrasound. (fulltekst) British Journal of General Practice Open 2017. ISSN 2398-3795.s doi: 10.3399/bjgpopen17X100893.
  • Besada, Emilio. Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab. (fulltekst) BMC Musculoskeletal Disorders 2016; Volum 17:6. ISSN 1471-2474.s 1 - 7.s doi: 10.1186/s12891-015-0860-3.
  • Besada, Emilio. Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab. (fulltekst) Autoimmune Diseases 2016; Volum 2016. ISSN 2090-0430.s doi: 10.1155/2016/8095695.
  • Besada, Emilio; Nossent, Johannes. CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in Granulomatosis with polyangiitis patients. PeerJ 2016; Volum 4:e2487. ISSN 2167-8359.s doi: 10.7717/peerj.2487.
  • GEO-RA group, GEO-RA group; Diamantopoulos, Andreas P; Mæland, Elisabeth; Besada, Emilio. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. (fulltekst) Clinical Rheumatology 2016. ISSN 0770-3198.s doi: 10.1007/s10067-016-3481-9.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans C. Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis. (fulltekst) PeerJ Preprints 2015. ISSN 2167-9843.s doi: 10.7287/peerj.preprints.972v1.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans. Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis. (fulltekst) PeerJ 2015; Volum 2015 (6). ISSN 2167-8359.s doi: 10.7717/peerj.1051.
  • Besada, Emilio. Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical review. Patient Preference and Adherence 2014; Volum 2014 (8). ISSN 1177-889X.s 1051 - 1059.s doi: 10.2147/PPA.S34958.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis. Rheumatology 2014; Volum 53 (6). ISSN 1462-0324.s doi: 10.1093/rheumatology/keu194.
  • Besada, Emilio; Njålla, Rune Johan; Nossent, Johannes C. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis. Rheumatology International 2013; Volum 33 (10). ISSN 0172-8172.s 2687 - 2689.s doi: 10.1007/s00296-012-2483-4.
  • Besada, Emilio. Pneumocystis jiroveci pneumonia prophylaxis is a challenge in granulomatosis with polyangiitis patients treated with rituximab. PeerJ Preprints 2013; Volum 1. ISSN 2167-9843.s doi: 10.7287/peerj.preprints.149v1.
  • Besada, Emilio; Bader, Lucius; Nossent, Johannes C. Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases. Rheumatology International 2013; Volum 33 (6). ISSN 0172-8172.s 1643 - 1644.s doi: 10.1007/s00296-011-2353-5.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre. Rheumatology 2013; Volum 52 (11). ISSN 1462-0324.s 2041 - 2047.s doi: 10.1093/rheumatology/ket257.
  • Besada, Emilio; Nossent, Johannes C. Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?. Clinical Rheumatology 2013; Volum 32 (11). ISSN 0770-3198.s 1677 - 1681.s doi: 10.1007/s10067-013-2293-4.
  • Besada, Emilio; Vik, Anders; Koldingsnes, Wenche; Nossent, Johannes C. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review. International journal of hematology 2013; Volum 97 (6). ISSN 0925-5710.s 800 - 803.s doi: 10.1007/s12185-013-1323-y.
  • Besada, Emilio; Nikolaisen, Cathrin; Nossent, Johannes C. Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?. Scandinavian Journal of Rheumatology 2012; Volum 41 (2). ISSN 0300-9742.s 85 - 88.s doi: 10.3109/03009742.2011.617316.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center. QJM: Quarterly journal of medicine 2012; Volum 105 (6). ISSN 1460-2725.s 545 - 550.s doi: 10.1093/qjmed/hcs015.
  • Besada, Emilio; Nossent, Johannes C. Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab. Clinical Rheumatology 2012; Volum 31 (8). ISSN 0770-3198.s 1263 - 1265.s doi: 10.1007/s10067-012-2007-3.
  • Besada, Emilio; Bader, Lucius; Nossent, Johannes C. Sustained hypogammaglobulinemia under rituximab maintenance could increase the risk for serious infections: a report of two cases. Rheumatology International 2011. ISSN 0172-8172.s doi: 10.1007/s00296-011-2353-5.
  • Besada, Emilio; Nikolaisen, Cathrin; Nossent, Johannes C. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis. Clinical and Experimental Rheumatology 2011; Volum 29 (1). ISSN 0392-856X.s 85 - 88.
  • Besada, Emilio. Rapid growing mycobacteria and TNF-alpha blockers: case report of a fatal lung infection with Mycobacterium abscessus in a patient treated with infliximab, and literature review. Clinical and Experimental Rheumatology 2011; Volum 29 (4). ISSN 0392-856X.s 705 - 707.
  • Besada, Emilio; Nossent, Johannes C. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clinical Rheumatology 2010; Volum 29 (5). ISSN 0770-3198.s 567 - 571.s doi: 10.1007/s10067-010-1375-9.
  • Besada, Emilio; Nikolaissen, C.; Nossent, Johannes. Diagnostic value of antibodies against citrullinated vimentin in rheumatoid arthritis. Scandinavian Journal of Rheumatology. Supplement 2010 (124). ISSN 0301-3847.s 28 - 28.
  • Besada, Emilio. Re: En pasient i 20-årene med icterus og smerter i ledd og muskler. Tidsskrift for Den norske legeforening 2016; Volum 136 (22). ISSN 0029-2001.s 1875 - 1876.s doi: 10.4045/tidsskr.16.0972.
  • Besada, Emilio; Nossent, Hans C. CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in Granulomatosis with polyangiitis patients.. Norsk rheumabulletin 2016; Volum 1. ISSN 1892-090X.s 36 - 37.
  • Besada, Emilio. Rituximab-induced hypogammaglobulinemia and intravenous immunoglobulin replacement therapy do not protect against relapse in granulomatous with polyangiitis. (fulltekst) Scandinavian Journal of Rheumatology. Supplement 2016; Volum 45. ISSN 0301-3847.s 48 - 48.
  • Besada, Emilio. Klinisk icterus med normal bilirubin nivå?. (fulltekst) Tidsskrift for Den norske legeforening 2016. ISSN 0029-2001.
  • Besada, Emilio. Er det forskjell på subkutan og intravenøs tocilizumab ved behandling av revmatoid artritt?. Revmatologi BestPractice 2015; Volum 7 (24).s 9 - 11.
  • Besada, Emilio. Comment on: Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice. (fulltekst) Rheumatology 2015; Volum 54 (4). ISSN 1462-0324.s 751 - .s doi: 10.1093/rheumatology/keu467.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans. Chronic nasal carriage of Staphylococcus aureus does not increase the risk of relapse and severe infections in granulomatosis with polyangiitis patients when receiving rituximab maintenance. Norsk rheumabulletin 2015 (1). ISSN 1892-090X.s 48 - 48.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Hans. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre.. Norsk rheumabulletin 2015; Volum 1. ISSN 1892-090X.s 48 - 49.
  • Besada, Emilio; Diamantopoulos, Andreas P. Does concomitant methotrexate during rituximab treatment in granulomatosis with polyangiitis (Wegener's) increase the risk of severe infection? Comment on the article by Azar et al. Arthritis & Rheumatology 2015; Volum 67 (7). ISSN 2326-5191.s 1981 - 1982.s doi: 10.1002/art.39144.
  • Besada, Emilio. Høydepunkter fra det internasjonale vaskulittmøtet i London. Norsk rheumabulletin 2015 (2). ISSN 1892-090X.s 38 - 39.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. CHRONIC NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS DOES NOT INCREASE THE RISK OF RELAPSE AND SEVERE INFECTIONS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS WHEN RECEIVING RITUXIMAB MAINTENANCE TREATMENT. Annual European Congress of Rheumatology 2014-06-11 - 2014-06-14 2014.
  • Besada, Emilio; Nossent, Johannes C. LOW CD4/CD8 RATIO IS ASSOCIATED WITH LOWER IMMUNOGLOBULIN LEVELS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS RECEIVING RITUXIMAB. Annual European Congress of Rheumatology 2014-06-11 - 2014-06-14 2014.
  • Besada, Emilio; Nossent, Johannes C. LOW CD4/CD8 RATIO IS ASSOCIATED WITH LOWER IMMUNOGLOBULIN LEVELS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS RECEIVING RITUXIMAB. Annals of the Rheumatic Diseases 2014; Volum 73. ISSN 0003-4967.s 556 - 556.s doi: 10.1136/annrheumdis-2014-eular.4915.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. CHRONIC NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS DOES NOT INCREASE THE RISK OF RELAPSE AND SEVERE INFECTIONS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS WHEN RECEIVING RITUXIMAB MAINTENANCE TREATMENT. Annals of the Rheumatic Diseases 2014; Volum 73. ISSN 0003-4967.s 556 - 556.s doi: 10.1136/annrheumdis-2014-eular.5231.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Chronic nasal carriage of Staphylococcus aureus in granulomatosis with polyangiitis patients receiving rituximab maintenance: friend or foe?. Scandinavian Journal of Rheumatology 2014; Volum 43. ISSN 0300-9742.s 49 - 50.
  • Besada, Emilio; Nossent, Johannes C. Low CD4/CD8 ratio is associated with lower immunoglobulin levels in granulomatosis with polyangiitis patients receiving rituximab. Scandinavian Journal of Rheumatology 2014; Volum 43. ISSN 0300-9742.s 49 - 49.
  • Besada, Emilio. Alkaptonuria-ochronosis: autosomal recessive OA?. Cartilage week 2014-09-01 - 2014-09-05 2014.
  • Besada, Emilio; Nossent, Johannes C. Low CD4/CD8 ratio is associated with lower immunoglobulin levels in granulomatosis with polyangiitis patients receiving rituximab. Scandinavian Congress of Rheumatology 2014-09-20 - 2014-09-23 2014.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Chronic nasal carriage of Staphylococcus aureus in granulomatosis with polyangiitis patients receiving rituximab maintenance: friend or foe?. Scandinavian Congress of Rheumatology 2014-09-20 - 2014-09-23 2014.
  • Besada, Emilio. UL diagnostikk hofte. Idrettsmedisinsk høstkongress 2014-11-07 - 2014-11-09 2014.
  • Besada, Emilio. Ultralyd veiledet injeksjon, hofte. Idrettsmedisinsk høstkongress 2014-11-07 - 2014-11-09 2014.
  • Besada, Emilio. Effekt og bivirkninger av rituxmab behandling hos pasienter med granulomatois with polyangiitis (GPA). Nyheter innen revmatologien (NRF julemøtet) 2014-11-27 - 2014-11-28 2014.
  • Besada, Emilio. Kroniske Staphylococcus aureus kolonisering i nese hos pasienter med granulomatosis with polyangiitis (GPA) som behandles med rituximab. Nyheter innen revmatologien (NRF julemøtet) 2014-11-27 - 2014-11-28 2014.
  • Besada, Emilio. Is there an interactive effect of immunoglobulin levels and CD4+ cell counts during rituximab treatment? Comment on the article by Mélet et al. Arthritis and Rheumatism 2014; Volum 66 (4). ISSN 0004-3591.s 1053 - 1054.s doi: 10.1002/art.38358.
  • Boggs, Will; Besada, Emilio. Tocilizumab allows steroid reduction in rheumatoid arthritis. (data) 2014.
  • Boggs, Will; Besada, Emilio. Tocilizumab allows steroid reductions in rheumatoid arthritis. (data) 2014.
  • Besada, Emilio. Do immunoglobulin levels and CD4 cell count interact during Rituximab treatment?. Arthritis and Rheumatism 2014. ISSN 0004-3591.s doi: 10.1002/art.38358.
  • Besada, Emilio. Fordeler med å bruke antistoffer mot citrullinert vimentin ved revmatoid arthrit?. Revmatologi BestPractice 2014; Volum 6 (19).s 10 - 11.
  • Besada, Emilio. Rituximab to be used with caution. 2013.
  • Besada, Emilio; Nossent, Johannes C. Infection Risks During Longterm Rituximab Therapy Change Over Time. Journal of Rheumatology 2013; Volum 40 (2). ISSN 0315-162X.s 203 - 203.s doi: 10.3899/jrheum.121247.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre. EUVAS 2013-04-13 - 2013.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: results from a single centre. La Médicale 2013; Volum 42 (4). ISSN 0755-4982.s 777 - 777.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance. EUVAS 2013-04-13 - 2013-04-17 2013.
  • Besada, Emilio; Koldingsnes, Wenche; Nossent, Johannes C. Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance. La Médicale 2013; Volum 42 (4). ISSN 0755-4982.s 767 - 768.
  • Besada, Emilio. Routine Pneumocystis Pneumonia Prophylaxis in Patients Treated With Rituximab?. Chest 2013; Volum 144 (1). ISSN 0012-3692.s 359 - 360.s doi: 10.1378/chest.13-0530.
  • Besada, Emilio; Nossent, Johannes C. Efficacy of chronic pre-emptive rituximab treatment in ANCA-associated vasculitis. Scandinavian Journal of Rheumatology 2012; Volum 41. ISSN 0300-9742.s 41 - 42.
  • Besada, Emilio. Alternative explanations for development of late-onset neutropenia in rituximab-treated rheumatic disease patients: Comment on the article by Tesfa et al. Arthritis and Rheumatism 2012; Volum 64 (2). ISSN 0004-3591.s 596 - 597.s doi: 10.1002/art.33428.
  • Besada, Emilio; Nossent, Johannes C. CRP as a marker for myocardial infarction and for damage accrual in systemic lupus erythematosus patients: results from a single-centre longitudinal study. Scandinavian Journal of Rheumatology 2012; Volum 41. ISSN 0300-9742.s 60 - 61.
  • Besada, Emilio; Nossent, Johannes C. CRP as a marker for myocardial infarction and for damage accrual in systemic lupus erythematosus: results from a single-center longitudinal study. 34th Scandinavian Congress of Rheumatology 2012-09-02 - 2012-09-05 2012.
  • Besada, Emilio; Nossent, Johannes C. Efficacy of chronic pre-emptive rituximab treatment in ANCA-associated vasculitis. 34th Scandinavian Congress of Rheumatology 2012-09-02 - 2012-09-05 2012.
  • Besada, Emilio. Rituximab og nøytropeni. Tidsskrift for Den norske legeforening 2012; Volum 132 (20). ISSN 0029-2001.s 2259 - 2259.
  • Nikolaisen, Cathrin; Besada, Emilio; Nossent, Johannes C. Nye kriterier for revmatoid artritt. (fulltekst) Tidsskrift for Den norske legeforening 2012; Volum 132 (2). ISSN 0029-2001.s 175 - 177.
  • Besada, Emilio; Nikolaissen, C.; Nossent, Johannes. Diagnostic value of antibodies against citrullinated vimentin in rheumatoid arthritis. Scandinavian Congress of Rheumatology 2010 2010-05-09 - 2010-05-12 2010.
  • Rabodonirina, Meja; Cotte, Laurent; Radenne, Sylvie; Besada, Emilio; Trepo, Christian. Microsporidiosis and transplantation: a retrospective study of 23 fases. Journal of Eukaryotic Microbiology 2003. ISSN 1066-5234.
    • Se alle arbeider i CRIStin →

    Forskningsinteresser

    Vasculitides - stor kar og ANCA-vasculitt

    Revmatoid arthritt

    Autoimmune sykdomer

    Opportunistiske infeksjoner.

    Undervisning

    Undervisning i revmatologi, 2. og 6. året medisinske året.

    Undervising i klininikk undersøkelse metodikk i 3. året medisinske året.

     


    Medlem i forskningsgruppe

    Molekylær inflammasjon (MIRG - IKM)   Norsk innhold

    CV

    ORCID-ID: 0000-0002-7006-9201

    Nåværende stilling:

     ·        Universitetslektor ved Institutt for klinisk medisin, UiT Norges arktiske universitet (50 %) siden 1.1.2017

    ·        Overlege i revmatologi ved Finnmarkssykehuset i Kirkenes (20 %) siden oktober 2013

    ·        Overlege i revmatologi ved Regional vurderingsenhet for somatisk rehabilitering i Nord-Norge i Universitetssykehuset Nord-NorgeTromsø (50 %) siden juni 2018

     

    Utdanning / arbeidserfaring:

     ·        Legestudium og allmennlege spesialisering i 2003 ved Université Claude Bernard Lyon I, Frankrike

    ·        Allmennlege i Senja (Lenvik) kommune fra februar 2004 tom oktober 2005

    ·        Lege i spesialisering i Universitetssykehuset Nord-Norge Tromsø fra november 2005 tom september 2012

    o   Hovedutdanning i Revmatologi

    o   Sideutdanning i Indremedisin (hjertemedisin, infeksjonsmedisin og geriatri)

    ·        Stipendiat i Klinisk Medisin innen Revmatologi ved UiT Norges arktiske universitet fra oktober 2012 tom desember 2016.

    ·        Universitetslektor for legeutdanningen i Finnmark fra ved UiT Norges arktiske universitet i 20 % stilling fra mai 2017 tom mars 2019

    ·        Overlege i Revmatologi ved Rehabiliteringssenteret Nord Norges Kurbad i 20-50 % stilling fra mars 2014 tom juli 2019.

     

    Akademiske kvalifikasjoner:

     ·        Underviser studenter ved UiT Norges Arktiske Universitet innen revmatologi, klinisk topografi og undersøkelse metodikk siden oktober 2012

    ·        Leder for delemne i Medisinprofesjonsstudium ved  UiT Norges Arktiske Universitet siden februar 2019

    ·        OSCE ansvarlig i 2017, 2019 og 2020

    ·        Sensor for OSCE ved UiT Norges Arktiske Universitet siden 2015

    ·        Ekstern sensor for OSCE ved NTNU i 2019

    ·        Reviewer for flere internasjonale tidsskrift (219 Merit per publons.org)

    ·        Associate editor for BMC Muskuloskeletal Disorders.

    ·        Tidligere medlem i det Nasjonalt Fagrådet i Revmatologi mellom 2011 og 2015